Counselors in Monroe, WI Accepting Medicare

30 Counselors found. Showing 21 - 30

Courtney L Stewart, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2321    Fax: 815-756-2944

Rachel Andrews Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000

Elisabeth Ruth Atwell, MA, LPC, CSAC, ICS Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9352

Victoria Leigh Heath, APSW - TEMPORARY Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9393    Fax: 608-325-2139

Mickey D Rockey Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9307

Kathleen O Bond-crull, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9339    Fax: 608-325-2139

Jacob Anthony Thomas Lindstrand, MS, LPC-IT, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9352

Gina Ann Lundervold-foley, MS Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000

Shanna Anderson Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1518 11th St Ste 1-4, Monroe, WI 53566 Phone: 608-325-1070

Taylor M Gonzalez Counselor Medicare: Not Enrolled in Medicare Practice Location: N3152 State Road 81, Monroe, WI 53566 Phone: 608-328-9393    Fax: 608-328-9480

News Archive

FDA Drugs Advisory Committee recommends approval for Gilead Sciences' aztreonam for inhalation solution

Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).

Rome Statement for an HIV Cure calls for accelerated research

Members of the Advisory Board for a Global Scientific Strategy "Towards an HIV Cure" today launched the Rome Statement for an HIV Cure calling for an acceleration of HIV cure research. The announcement was made at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) currently being held in Rome

Wearable robotic exoskeleton could alleviate crouch gait in children with cerebral palsy

According to the Centers for Disease Control and Prevention, cerebral palsy (CP)-;caused by neurological damage before, during or after birth-;is the most common movement disorder in children, limiting mobility and independence throughout their lives.

Drug resistance gene has spread from East Coast to Midwest

A resistance gene that allows bacteria to beat an important class of antibiotics has started to appear in microorganisms taken from Midwestern patients, according to researchers at Washington University School of Medicine in St. Louis.

Positive results from LCP-Tacro Phase III trial in stable kidney transplant recipients

LifeCycle Pharma A/S today reported that the company's lead product candidate, LCP-Tacro, successfully demonstrated non-inferiority compared to tacrolimus in its Phase III trial, Study 3001.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)